A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC

BACKGROUND: Most patients with high-grade serous ovarian cancer (HGSOC) experienced disease recurrence with cumulative chemoresistance, leading to treatment failure. However, few biomarkers are currently available in clinical practice that can accurately predict chemotherapy response. The tumor immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Yue, Zhang, Yingchun, Zheng, Kun, Zou, Jiawei, Gui, Lv, Zou, Xin, Chen, Liang, Hao, Jie, Zhang, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382026/
https://www.ncbi.nlm.nih.gov/pubmed/37519793
http://dx.doi.org/10.3389/fonc.2023.1171582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382026/
https://www.ncbi.nlm.nih.gov/pubmed/37519793
http://dx.doi.org/10.3389/fonc.2023.1171582

Ejemplares similares